Close Menu

NEW YORK (360Dx) – BGN Technologies today announced a collaboration with Singapore medical diagnostics firm Biosensorix to develop quantitative point-of-care diagnostics.

The technology is an electrochemical lateral flow immunosensor test that can quantitatively diagnose disease-related biomarkers and pathogens. The device will be similar to a USB drive, BGN, the technology transfer company of Ben-Gurion University of the Negev, said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.